These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment. Wu JQ; Lu MP; Reed AM World J Pediatr; 2020 Feb; 16(1):31-43. PubMed ID: 31556011 [TBL] [Abstract][Full Text] [Related]
4. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis]. Cherin P Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990 [TBL] [Abstract][Full Text] [Related]
5. [Juvenile dermatomyositis]. Martini A; Ravelli A; Aramini L; Ramenghi B Pediatr Med Chir; 1990; 12(6):587-91. PubMed ID: 2093879 [TBL] [Abstract][Full Text] [Related]
6. Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use. Chiu YE; Co DO Pediatr Dermatol; 2011; 28(4):357-67. PubMed ID: 21793879 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous signs of classical dermatomyositis. Auriemma M; Capo A; Meogrossi G; Amerio P G Ital Dermatol Venereol; 2014 Oct; 149(5):505-17. PubMed ID: 25014587 [TBL] [Abstract][Full Text] [Related]
10. Increasing recognition of dermatomyositis with subcutaneous edema - is this a poorer prognostic marker? Tu J; McLean-Tooke A; Junckerstorff R Dermatol Online J; 2014 Jan; 20(1):21244. PubMed ID: 24456947 [TBL] [Abstract][Full Text] [Related]
12. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Feldman BM; Rider LG; Reed AM; Pachman LM Lancet; 2008 Jun; 371(9631):2201-12. PubMed ID: 18586175 [TBL] [Abstract][Full Text] [Related]
13. Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey. Stringer E; Bohnsack J; Bowyer SL; Griffin TA; Huber AM; Lang B; Lindsley CB; Ota S; Pilkington C; Reed AM; Scuccimarri R; Feldman BM J Rheumatol; 2010 Sep; 37(9):1953-61. PubMed ID: 20595275 [TBL] [Abstract][Full Text] [Related]
14. Update on the clinical management of juvenile dermatomyositis. Huber AM Expert Rev Clin Immunol; 2018 Dec; 14(12):1021-1028. PubMed ID: 30308133 [TBL] [Abstract][Full Text] [Related]
15. Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Wedderburn LR; Rider LG Best Pract Res Clin Rheumatol; 2009 Oct; 23(5):665-78. PubMed ID: 19853831 [TBL] [Abstract][Full Text] [Related]